Join the club for FREE to access the whole archive and other member benefits.

Life Biosciences

Drug development company promoting longevity and finding treatments for age-related diseases

Founded in 2017 and headquartered in Boston, MA, Life Biosciences is pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop pharmaceutical treatments with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.

Aging is the biggest risk factor for almost every chronic disease. Ground-breaking research over the past decade has shown that aging is a modifiable risk factor that can be targeted therapeutically. Developing medicines that modify aging biology to prevent, delay, and/or reverse diseases of aging has the potential to transform the practice of medicine.

Visit website: https://lifebiosciences.com/

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

People at Life Biosciences

Company Representative

Dr. Mehmood Khan is a CEO of Life Biosciences

Company Representative

Tristan Edwards is a Co-Founder & Chief Investment Officer at Life Biosciences

Life Biosciences News

Investing in the Longevity industry

Longevity Technology - 18-Sep-2019

Edwards believes 20–30 years will be added to the average lifespan with none of the ageing diseases

Read more...

Today's 50 year-olds may live another 100 years

Forbes - 26-Aug-2019

Good summary of some major investments in life extension companies

Read more...